ReShape LifeSciences

ReShape has developed a non-surgical weight-loss device and counselling program. The CE-Marked and FDA-approved ReShape Dual is an intra-gastric, dual-balloon system. The device aims to help the 60 million Americans with a body mass index (BMI) between 30 and 40 achieve their weight-loss goals.

The device is implanted in the stomach via a simple and rapid endoscopic procedure, filled with a saline solution, and removed after six months. Patients undergoing the procedure also receive one year of nutritional counselling. ReShape is positioned to be a new entrant in the large, untapped US market for non-surgical weight loss devices